Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5817028 | ARNA PHARMA | Method and device for the provocation of air passage narrowing and/or the induction of sputum |
Feb, 2015
(9 years ago) |
Drug Exclusivity | Drug Exclusivity Expiration |
---|---|
New Product(NP) | Oct 05, 2013 |
Drugs and Companies using MANNITOL ingredient
Market Authorisation Date: 05 October, 2010
Treatment: Assessment of bronchial hyperresponsiveness in patients 6 years of age or older who do not have clinically apparent asthma
Dosage: POWDER;INHALATION